The qRT‐PCR results confirmed that the expression levels of ATF4, FOXO3, TFEB, and p53 (TP53) consistently increased in HCC cells in response to different concentrations of sorafenib (Figure 6E). The gene discussed is TFEB; the disease is hepatocellular carcinoma.